Could this be the case of a blown-up long-term opportunity? Y-Mabs Therapeutics Inc (YMAB)
Y-Mabs Therapeutics Inc [YMAB] stock is trading at $4.69, up 3.30%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The YMAB shares have gain 7.82% over the last week, with a monthly amount drifted -4.29%, and not seem to be holding up well over […]